Thu. Feb 12th, 2026

[Alloy Therapeutics in Business Wire] Alloy accelerates Mediar timeline to the clinic for complex fibrosis targets


BOSTON–(BUSINESS WIRE)–Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting-edge drug discovery technologies, today announced the successful completion of an antibody discovery collaboration with Mediar Therapeutics. 

Read more here.

By uttu

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *